Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages

Journal of Nutritional Biochemistry

Volumn 21, Issue 5, 2010, Pages 444-450

  Mullen, Anne ^a   Loscher, Christine E ^a   Roche, Helen M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cytokines; DHA; EPA; Lipopolysaccharide; Macrophages; NF B

Indexed keywords

DOCOSAHEXAENOIC ACID; I KAPPA B KINASE ALPHA; I KAPPA B KINASE INHIBITOR; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE ACTIVATION; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANTI-INFLAMMATORY AGENTS; CARDIOTONIC AGENTS; CELL LINE; DOCOSAHEXAENOIC ACIDS; DOWN-REGULATION; EICOSAPENTAENOIC ACID; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; IMMUNOMODULATION; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; METABOLIC SYNDROME X; NF-KAPPA B P50 SUBUNIT; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR RELA;

EID: 77951497987     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.02.008     Document Type: Article

References (43)

1. Storlien L.H., Kraegen E.W., Chisholm D.J., Ford G.L., Bruce D.G., Pascoe W.S. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987, 237(4817):885-888.
2. Harris W.S., Connor W.E., Alam N., Illingworth D.R. Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res 1988, 29(11):1451-1460.
3. Babcock T.A., Kurland A., Helton W.S., Rahman A., Anwar K.N., Espat N.J. Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. JPEN J Parenter Enteral Nutr 2003, 27(3):176-180. [discussion 81].
4. Yaqoob P., Calder P.C. N-3 polyunsaturated fatty acids and inflammation in the arterial wall. Eur J Med Res 2003, 8(8):337-354.
5. Mori T.A., Beilin L.J. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 2004, 6(6):461-467.
6. Abeywardena M.Y., Head R.J. Dietary polyunsaturated fatty acid and antioxidant modulation of vascular dysfunction in the spontaneously hypertensive rat. Prostaglandins Leukot Essent Fatty Acids 2001, 65(2):91-97.
7. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361(9356):477-485.
8. D'Alessandro M.E., Chicco A., Karabatas L., Lombardo Y.B. Role of skeletal muscle on impaired insulin sensitivity in rats fed a sucrose-rich diet: effect of moderate levels of dietary fish oil. J Nutr Biochem 2000, 11(5):273-280.
9. Peyron-Caso E., Fluteau-Nadler S., Kabir M., Guerre-Millo M., Quignard-Boulange A., Slama G., et al. Regulation of glucose transport and transporter 4 (GLUT-4) in muscle and adipocytes of sucrose-fed rats: effects of N-3 poly- and monounsaturated fatty acids. Horm Metab Res 2002, 34(7):360-366.
10. Ghafoorunissa, Ibrahim A., Rajkumar L., Acharya V. Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J Nutr 2005, 135(11):2634-2638.
11. Winzell M.S., Pacini G., Ahren B. Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice. Am J Physiol Endocrinol Metab 2006, 290(2):E347-E354.
12. Klein-Platat C., Drai J., Oujaa M., Schlienger J.L., Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005, 82(6):1178-1184.
13. Haugaard S.B., Madsbad S., Hoy C.E., Vaag A. Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clin Endocrinol (Oxf) 2006, 64(2):169-178.
14. Roche H.M. Fatty acids and the metabolic syndrome. Proc Nutr Soc 2005, 64(1):23-29.
15. Weisberg S.T., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112(12):1796-1808.
16. Neels J.G., Olefsky J.M. Inflamed fat: what starts the fire?. J Clin Invest 2006, 116(1):33-35.
17. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112(12):1785-1788.
18. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112(12):1821-1830.
19. Vitseva O.I., Tanriverdi K., Tchkonia T.T., Kirkland J.L., McDonnell M.E., Apovian C.M., et al. Inducible toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008, 16(5):932-937.
20. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995, 95(5):2409-2415.
21. Senn J.J., Klover P.J., Nowak I.A., Zimmers T.A., Koniaris L.G., Furlanetto R.W., et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003, 278(16):13740-13746.
22. Jager J., Grémeaux T., Cormont M., Le Marchand-Brustel Y., Tanti J.F. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007, 148(1):241-251.
23. Lagathu C., Yvan-Charvet L., Bastard J.P., Maachi M., Quignard-Boulange A., Capeau J., et al. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 2006, 49(9):2162-2173.
24. Roshak A.K., Callahan J.F., Blake S.M. Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease. Curr Opin Pharmacol 2002, 2(3):316-321.
25. Vermeulen L., De Wilde G., Notebaert S., Vanden Berghe W., Haegeman G. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 2002, 64(5-6):963-970.
26. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683.
27. Baer M., Dillner A., Schwartz R.C., Sedon C., Nedospasov S., Johnson P.F. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol Cell Biol 1998, 18(10):5678-5689.
28. Collins T., Cybulsky M.I. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?. J Clin Invest 2001, 107(3):255-264.
29. Karin M., Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000, 12(1):85-98.
30. Baldwin A.S. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001, 107(1):3-6.
31. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001, 107(1):7-11.
32. Liu P.P., Le J., Nian M. Nuclear factor-kappaB decoy: infiltrating the heart of the matter in inflammatory heart disease. Circ Res 2001, 89(10):850-852.
33. Babcock T.A., Helton W.S., Hong D., Espat N.J. Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-alpha production. Surg Infect (Larchmt) 2002, 3(2):145-149.
34. Novak T.E., Babcock T.A., Jho D.H., Helton W.S., Espat N.J. NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol 2003, 284(1):L84-L89.
35. Zhao Y., Joshi-Barve S., Barve S., Chen L.H. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 2004, 23(1):71-78.
36. Lo C.J., Chiu K.C., Fu M., Lo R., Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res 1999, 82(2):216-221.
37. Chu A.J., Walton M.A., Prasad J.K., Seto A. Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytic tissue factor activation is mediated by the depressed receptor expression in THP-1 cells. J Surg Res 1999, 87(2):217-224.
38. De Caterina R., Liao J.K., Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000, 71(1 Suppl):213S-223S.
39. Weldon S.M., Mullen A.C., Loscher C.E., Hurley L.A., Roche H.M. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 2007, 18(4):250-258.
40. Osborn L., Kunkel S., Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A 1989, 86(7):2336-2340.
41. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 2001, 276(20):16683-16689.
42. Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., et al. Differential modulation of toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003, 44(3):479-486.
43. Lee J.G., Lee S.H., Park D.W., Yoon H.S., Chin B.R., Kim J.H., et al. Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling. Cell Signal 2008, 20(1):105-111.